Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Who We Are: Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed
Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job Description Join Us as a Regulatory Affairs Associate Director – Make an Impact at the Forefront of Innovation We have successfully supported the top 50 pharmaceutical companies and more than 750